Update on bb2121, Potential Advanced Multiple Myeloma Therapy, Set for ASCO 2018
Celgene’s investigational and second-generation CAR T-cell therapy bb2121 is…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Recruitment Open for Phase 2 Trial Aimed at Complete Eradication of Myeloma Cells
The University of Alabama at Birmingham (UAB)…
FDA Names Cancer Vaccine Galinpepimut-S Orphan Drug as Possible Multiple Myeloma Treatment
The investigational cancer vaccine galinpepimut-S (GPS) has been…
FDA Approves Darzalex Combo Therapy for Certain Newly Diagnosed Patients
The U.S. Food and Drug Administration (FDA) has approved …
Selinexor May Bring Hope to Heavily Treated Myeloma Patients, Trial Results Show
A quarter of heavily treated patients with penta-refractory…
9/11 Firefighters at Greater Risk of Multiple Myeloma Precursor, Study Reports
New York City firefighters exposed to the 9/11 World…
